Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Celani

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|November 28, 2023
Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions-The CAESAR studySabrina Giometto, Marco Finocchietti, Olga Paoletti, et al.
The Cochrane Database of Systematic Reviews|October 13, 2009
Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptomsMiriam Brazzelli, Peter Ag Sandercock, Francesca M Chappell, et al.
BMJ Supportive & Palliative Care|April 9, 2021
People with amyotrophic lateral sclerosis and their caregivers: what matters most?Paola Brunori, Maria Grazia Celani, Angelo Alberto Bignamini, et al.
Assistenza Infermieristica E Ricerca : AIR|May 10, 2002
[Variability in the delivery of care in stroke units: analysis of the protocols]Elisabetta Balestra, Maria Grazia Celani, Roberta Del Santo, et al.
European Journal of Neurology|September 19, 2024
Pharmacological and non-pharmacological treatments in amyotrophic lateral sclerosis: an Italian real-world data studyOlga Paoletti, Giulia Hyeraci, Marco Finochietti, et al.
Resuscitation|August 16, 2020
Is there inter-observer variation in the interpretation of SSEPs in comatose cardiac arrest survivors? Further considerations following the Italian multicenter ProNeCa studyMaria Grazia Celani, Riccardo Carrai, Teresa Anna Cantisani, et al.
Data in Brief|November 26, 2019
Neurophysiological and neuroradiological test for early poor outcome (Cerebral Performance Categories 3-5) prediction after cardiac arrest: Prospective multicentre prognostication dataMaenia Scarpino, Francesco Lolli, Giovanni Lanzo, et al.
Resuscitation|December 18, 2020
Does a combination of ≥2 abnormal tests vs. the ERC-ESICM stepwise algorithm improve prediction of poor neurological outcome after cardiac arrest? A post-hoc analysis of the ProNeCA multicentre studyMaenia Scarpino, Francesco Lolli, Giovanni Lanzo, et al.
Resuscitation|August 11, 2019
Neurophysiology and neuroimaging accurately predict poor neurological outcome within 24 hours after cardiac arrest: The ProNeCA prospective multicentre prognostication studyMaenia Scarpino, Francesco Lolli, Giovanni Lanzo, et al.
Neuroepidemiology|October 9, 2024
Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic ReviewFrancesco Sciancalepore, Niccolò Lombardi, Giulia Valdiserra, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|November 28, 2023
Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions-The CAESAR studySabrina Giometto, Marco Finocchietti, Olga Paoletti, et al.
The Cochrane Database of Systematic Reviews|October 13, 2009
Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptomsMiriam Brazzelli, Peter Ag Sandercock, Francesca M Chappell, et al.
BMJ Supportive & Palliative Care|April 9, 2021
People with amyotrophic lateral sclerosis and their caregivers: what matters most?Paola Brunori, Maria Grazia Celani, Angelo Alberto Bignamini, et al.
Assistenza Infermieristica E Ricerca : AIR|May 10, 2002
[Variability in the delivery of care in stroke units: analysis of the protocols]Elisabetta Balestra, Maria Grazia Celani, Roberta Del Santo, et al.
European Journal of Neurology|September 19, 2024
Pharmacological and non-pharmacological treatments in amyotrophic lateral sclerosis: an Italian real-world data studyOlga Paoletti, Giulia Hyeraci, Marco Finochietti, et al.
Resuscitation|August 16, 2020
Is there inter-observer variation in the interpretation of SSEPs in comatose cardiac arrest survivors? Further considerations following the Italian multicenter ProNeCa studyMaria Grazia Celani, Riccardo Carrai, Teresa Anna Cantisani, et al.
Data in Brief|November 26, 2019
Neurophysiological and neuroradiological test for early poor outcome (Cerebral Performance Categories 3-5) prediction after cardiac arrest: Prospective multicentre prognostication dataMaenia Scarpino, Francesco Lolli, Giovanni Lanzo, et al.
Resuscitation|December 18, 2020
Does a combination of ≥2 abnormal tests vs. the ERC-ESICM stepwise algorithm improve prediction of poor neurological outcome after cardiac arrest? A post-hoc analysis of the ProNeCA multicentre studyMaenia Scarpino, Francesco Lolli, Giovanni Lanzo, et al.
Resuscitation|August 11, 2019
Neurophysiology and neuroimaging accurately predict poor neurological outcome within 24 hours after cardiac arrest: The ProNeCA prospective multicentre prognostication studyMaenia Scarpino, Francesco Lolli, Giovanni Lanzo, et al.
Neuroepidemiology|October 9, 2024
Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic ReviewFrancesco Sciancalepore, Niccolò Lombardi, Giulia Valdiserra, et al.
Pageof 3